Skip to main content
Top
Published in: General Thoracic and Cardiovascular Surgery 5/2024

25-12-2023 | Computed Tomography | Original Article

The significance of regular chest computed tomography in postoperative surveillance for surgically resected non-small cell lung cancer based on TNM 8th staging system

Authors: Jun Suzuki, Tomohiro Miyoshi, Kenta Tane, Ken Onodera, Yutaro Koike, Takashi Sakai, Joji Samejima, Keiju Aokage, Masahiro Tsuboi

Published in: General Thoracic and Cardiovascular Surgery | Issue 5/2024

Login to get access

Abstract

Objectives

Although several societies recommend regular chest computed tomography (CT) scans for the surveillance of surgically resected non-small cell lung cancer (NSCLC), there is paucity of evidence to support these statements. This study aimed to clarify whether regular CT scans improved the prognosis of patients with surgically resected NSCLC based on TNM 8th classification.

Methods

Patients with pathologic Stage 0–III NSCLC who underwent complete surgical resection other than sublobar resection procedures were enrolled in the study. For these patients, clinicopathological data and postoperative surveillance data were collected by the retrospective review of medical records. Patients were categorized into the chest X-ray (CXR) group or the CT group according to whether they were followed-up with basic examinations including CXR or basic examinations plus regular chest CT. Postoperative overall survival was compared between the two groups.

Results

Six hundred sixty five patients were categorized into the CXR (n = 245) and CT (n = 420) groups. The clinicopathological backgrounds did not differ to a statistically significant extent. Recurrence was seen in 68 (27.3%) patients in the CXR group and 117 (27.8%) patients in the CT group. The 5-year overall survival rates of the two groups did not differ to a statistically significant extent (CXR, 76.5%; CT, 78.3%, P = 0.22).

Conclusion

Regular chest CT scans may not improve the prognosis of surgically resected NSCLC. Further study is warranted to precisely evaluate the benefit of CT-based postoperative surveillance of NSCLC.
Appendix
Available only for authorised users
Literature
1.
2.
3.
go back to reference Colt HG, et al. Follow-up and surveillance of the patient with lung cancer after curative-intent therapy: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2013;143(5 Suppl):e437S-e454S.CrossRefPubMed Colt HG, et al. Follow-up and surveillance of the patient with lung cancer after curative-intent therapy: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2013;143(5 Suppl):e437S-e454S.CrossRefPubMed
4.
go back to reference Vansteenkiste J, et al. 2nd ESMO consensus conference on lung cancer: early-stage non-small-cell Lung cancer: early-stage non-small-cell lung cancer consensus on diagnosis, treatment and follow-up. Ann Oncol. 2014;25(8):1462–74.CrossRefPubMed Vansteenkiste J, et al. 2nd ESMO consensus conference on lung cancer: early-stage non-small-cell Lung cancer: early-stage non-small-cell lung cancer consensus on diagnosis, treatment and follow-up. Ann Oncol. 2014;25(8):1462–74.CrossRefPubMed
5.
go back to reference Westeel V, et al. Relevance of an intensive postoperative follow-up after surgery for non-small cell lung cancer. Ann Thorac Surg. 2000;70(4):1185–90.CrossRefPubMed Westeel V, et al. Relevance of an intensive postoperative follow-up after surgery for non-small cell lung cancer. Ann Thorac Surg. 2000;70(4):1185–90.CrossRefPubMed
6.
go back to reference Nakamura R, et al. Postoperative follow-up for patients with non-small cell lung cancer. Onkologie. 2010;33(1–2):14–8.PubMed Nakamura R, et al. Postoperative follow-up for patients with non-small cell lung cancer. Onkologie. 2010;33(1–2):14–8.PubMed
7.
go back to reference Chiu CH, et al. Usefulness of low-dose spiral CT of the chest in regular follow-up of postoperative non-small cell lung cancer patients: preliminary report. J Thorac Cardiovasc Surg. 2003;125(6):1300–5.CrossRefPubMed Chiu CH, et al. Usefulness of low-dose spiral CT of the chest in regular follow-up of postoperative non-small cell lung cancer patients: preliminary report. J Thorac Cardiovasc Surg. 2003;125(6):1300–5.CrossRefPubMed
8.
go back to reference Younes RN, Gross JL, Deheinzelin D. Follow-up in lung cancer: how often and for what purpose? Chest. 1999;115(6):1494–9.CrossRefPubMed Younes RN, Gross JL, Deheinzelin D. Follow-up in lung cancer: how often and for what purpose? Chest. 1999;115(6):1494–9.CrossRefPubMed
9.
go back to reference McMurry TL, et al. More frequent surveillance following lung cancer resection is not associated with improved survival: a nationally representative cohort study. Ann Surg. 2018;268(4):632–9.CrossRefPubMed McMurry TL, et al. More frequent surveillance following lung cancer resection is not associated with improved survival: a nationally representative cohort study. Ann Surg. 2018;268(4):632–9.CrossRefPubMed
10.
go back to reference Travis WD, et al. The 2015 world health organization classification of lung tumors: impact of genetic, clinical and radiologic advances since the 2004 classification. J Thorac Oncol. 2015;10(9):1243–60.CrossRefPubMed Travis WD, et al. The 2015 world health organization classification of lung tumors: impact of genetic, clinical and radiologic advances since the 2004 classification. J Thorac Oncol. 2015;10(9):1243–60.CrossRefPubMed
11.
go back to reference Goldstraw P, et al. The IASLC lung cancer staging project: proposals for revision of the TNM stage groupings in the forthcoming (Eighth) edition of the TNM classification for lung cancer. J Thorac Oncol. 2016;11(1):39–51.CrossRefPubMed Goldstraw P, et al. The IASLC lung cancer staging project: proposals for revision of the TNM stage groupings in the forthcoming (Eighth) edition of the TNM classification for lung cancer. J Thorac Oncol. 2016;11(1):39–51.CrossRefPubMed
12.
go back to reference Mayne NR, et al. Impact of surveillance after lobectomy for lung cancer on disease detection and survival. Clin Lung Cancer. 2020;21(5):407–14.CrossRefPubMed Mayne NR, et al. Impact of surveillance after lobectomy for lung cancer on disease detection and survival. Clin Lung Cancer. 2020;21(5):407–14.CrossRefPubMed
13.
go back to reference Martini N, Melamed MR. Multiple primary lung cancers. J Thorac Cardiovasc Surg. 1975;70(4):606–12.CrossRefPubMed Martini N, Melamed MR. Multiple primary lung cancers. J Thorac Cardiovasc Surg. 1975;70(4):606–12.CrossRefPubMed
14.
go back to reference Walsh GL, et al. Is follow-up of lung cancer patients after resection medically indicated and cost-effective? Ann Thorac Surg. 1995;60(6):1563–70.CrossRefPubMed Walsh GL, et al. Is follow-up of lung cancer patients after resection medically indicated and cost-effective? Ann Thorac Surg. 1995;60(6):1563–70.CrossRefPubMed
15.
go back to reference Westeel V, et al. Chest CT scan plus x-ray versus chest x-ray for the follow-up of completely resected non-small-cell lung cancer (IFCT-0302): a multicentre, open-label, randomised, phase 3 trial. Lancet Oncol. 2022;23:1180.CrossRefPubMed Westeel V, et al. Chest CT scan plus x-ray versus chest x-ray for the follow-up of completely resected non-small-cell lung cancer (IFCT-0302): a multicentre, open-label, randomised, phase 3 trial. Lancet Oncol. 2022;23:1180.CrossRefPubMed
16.
go back to reference Korst RJ, et al. Surveillance computed tomography after complete resection for non-small cell lung cancer: results and costs. J Thorac Cardiovasc Surg. 2005;129(3):652–60.CrossRefPubMed Korst RJ, et al. Surveillance computed tomography after complete resection for non-small cell lung cancer: results and costs. J Thorac Cardiovasc Surg. 2005;129(3):652–60.CrossRefPubMed
17.
go back to reference van den Bergh KA, et al. Short-term health-related quality of life consequences in a lung cancer CT screening trial (NELSON). Br J Cancer. 2010;102(1):27–34.CrossRefPubMed van den Bergh KA, et al. Short-term health-related quality of life consequences in a lung cancer CT screening trial (NELSON). Br J Cancer. 2010;102(1):27–34.CrossRefPubMed
18.
go back to reference van den Bergh KA, et al. Long-term effects of lung cancer computed tomography screening on health-related quality of life: the NELSON trial. Eur Respir J. 2011;38(1):154–61.CrossRefPubMed van den Bergh KA, et al. Long-term effects of lung cancer computed tomography screening on health-related quality of life: the NELSON trial. Eur Respir J. 2011;38(1):154–61.CrossRefPubMed
19.
go back to reference Gareen IF, et al. Impact of lung cancer screening results on participant health-related quality of life and state anxiety in the National Lung Screening Trial. Cancer. 2014;120(21):3401–9.CrossRefPubMed Gareen IF, et al. Impact of lung cancer screening results on participant health-related quality of life and state anxiety in the National Lung Screening Trial. Cancer. 2014;120(21):3401–9.CrossRefPubMed
20.
21.
go back to reference Saji H, et al. Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer (JCOG0802/WJOG4607L): a multicentre, open-label, phase 3, randomised, controlled, non-inferiority trial. Lancet. 2022;399(10335):1607–17.CrossRefPubMed Saji H, et al. Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer (JCOG0802/WJOG4607L): a multicentre, open-label, phase 3, randomised, controlled, non-inferiority trial. Lancet. 2022;399(10335):1607–17.CrossRefPubMed
23.
go back to reference Chaudhuri AA, et al. Early detection of molecular residual disease in localized lung cancer by circulating tumor DNA profiling. Cancer Discov. 2017;7(12):1394–403.CrossRefPubMedPubMedCentral Chaudhuri AA, et al. Early detection of molecular residual disease in localized lung cancer by circulating tumor DNA profiling. Cancer Discov. 2017;7(12):1394–403.CrossRefPubMedPubMedCentral
24.
go back to reference Gale D, et al. Residual ctDNA after treatment predicts early relapse in patients with early-stage non-small cell lung cancer. Ann Oncol. 2022;33(5):500–10.CrossRefPubMed Gale D, et al. Residual ctDNA after treatment predicts early relapse in patients with early-stage non-small cell lung cancer. Ann Oncol. 2022;33(5):500–10.CrossRefPubMed
25.
26.
go back to reference Peters S, et al. MERMAID-1: a phase III study of adjuvant durvalumab plus chemotherapy in resected NSCLC patients with MRD+ post-surgery. J Thorac Oncol. 2021;16(3):S258–9.CrossRef Peters S, et al. MERMAID-1: a phase III study of adjuvant durvalumab plus chemotherapy in resected NSCLC patients with MRD+ post-surgery. J Thorac Oncol. 2021;16(3):S258–9.CrossRef
Metadata
Title
The significance of regular chest computed tomography in postoperative surveillance for surgically resected non-small cell lung cancer based on TNM 8th staging system
Authors
Jun Suzuki
Tomohiro Miyoshi
Kenta Tane
Ken Onodera
Yutaro Koike
Takashi Sakai
Joji Samejima
Keiju Aokage
Masahiro Tsuboi
Publication date
25-12-2023
Publisher
Springer Nature Singapore
Published in
General Thoracic and Cardiovascular Surgery / Issue 5/2024
Print ISSN: 1863-6705
Electronic ISSN: 1863-6713
DOI
https://doi.org/10.1007/s11748-023-01991-y

Other articles of this Issue 5/2024

General Thoracic and Cardiovascular Surgery 5/2024 Go to the issue